XML 67 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Stockholders' Equity (deficit) (USD $)
In Thousands, except Share data, unless otherwise specified
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Deficit accumulated during the development stage
Series A convertible preferred stock
Series A convertible preferred stock
Convertible preferred stock
Series A convertible preferred stock
Common stock
Series A convertible preferred stock
Additional paid-in capital
Series B convertible preferred stock
Series B convertible preferred stock
Convertible preferred stock
Series B convertible preferred stock
Common stock
Series B convertible preferred stock
Additional paid-in capital
Balance at Apr. 04, 2011                          
Increase (decrease) in stockholders' equity                          
Sale of common stock to founders $ 1 $ 1                      
Sale of common stock to founders (in shares)   526,443                      
Vesting of restricted stock 1 1                      
Vesting of restricted stock (in shares)   683,309                      
Issuance of convertible preferred stock, net of issuance costs of $2,246 at 2012 and $101 at 2011 (101)   (101)       6,200            
Issuance of convertible preferred stock, net of issuance costs of $2,246 at 2012 and $101 at 2011 (in shares)             6,200,000            
Stock-based compensation expense 346   346                    
Net loss (2,624)       (2,624)                
Balance at Dec. 31, 2011 (2,377) 2 245   (2,624)   6,200            
Balance (in shares) at Dec. 31, 2011   1,209,752         6,200,000            
Increase (decrease) in stockholders' equity                          
Vesting of restricted stock 1 1                      
Vesting of restricted stock (in shares)   674,505                      
Issuance of convertible preferred stock, net of issuance costs of $2,246 at 2012 and $101 at 2011                     34,992    
Issuance of convertible preferred stock, net of issuance costs of $2,246 at 2012 and $101 at 2011 (in shares)                     6,770,563    
Conversion of Series A preferred stock to common stock 6,200 3 6,197                    
Common stock issued from the Conversion of Series A preferred stock to common stock (in shares)   3,064,753                      
Conversion of Series B preferred stock to common stock 34,992 7 34,985                    
Common stock issued from the Conversion of Series A preferred stock to common stock (in shares)   6,770,563                      
Conversion of preferred stock to common stock           6,200 (6,200) 3 6,197 34,992 (34,992) 7 34,985
Conversion of preferred stock to common stock (in shares)             (6,200,000) 3,064,753     (6,770,563) 6,770,563  
Common stock issued in a private placement, net of issuance costs of $898 4,039 1 4,038                    
Common stock issued in a private placement, net of issuance costs of $898 (in shares)   897,554                      
Stock options exercised (in shares)   5,792                      
Stock-based compensation expense 1,382   1,382                    
Unrealized loss on investments (6)     (6)                  
Net loss (13,510)       (13,510)                
Balance at Dec. 31, 2012 $ 30,721 $ 14 $ 46,847 $ (6) $ (16,134)                
Balance (in shares) at Dec. 31, 2012   12,622,919